From Committee of the Whole

Committee of the Whole, Wednesday morning / Thursday afternoon (L7. Advancing effective and innovative approaches, through national, regional, and international action, to address the multifaceted challenges posed by synthetic drugs, particularly synthetic opioids

USA: Thank you chair, we have had three sessions of informals and believe we have completed a review of the preamble so should be able to get through that but may need time or the operative paragraphs. Chair: We will now move through L7, is there any comments? Title approved. PP1 Australia: originally this pp …

Read more

Committee of the Whole – Monday afternoon (L6. Promoting Alternative Development as a development-oriented drug control strategy)

Title Chair: No comments PP1 Mexico: During consultations on this draft resolution, we had expressed our concern with the reference to the 2030 Agenda. We know for the US, it is important to have adequate language. We suggest “recalling” to be substituted with “as was reiterated”, to take into account the US proposal that there’s a …

Read more

Committee of the Whole – Monday afternoon (L5 – Enhancing forensic detection capability for synthetic drugs through increasing international collaboration)

Australia: Our resolution seeks to look at capability-building in the area of supply-reduction, particularly forensics. Primarily on health and safety, community protection and disposal. Hence references to information sharing. We have had good engagement in two informal sessions (Wednesday morning, and earlier today). Some text included now. All but two occasions agreed. Chair: Let’s consider the …

Read more

Committee of the Whole (Friday Afternoon) – Final meeting. Various resolutions.

L4.Rev 1 – Algeria, Andorra, Belarus, China, Indonesia, Pakistan, Russian Federation, Vietnam, Thailand, Sri Lanka, Switzerland… Outlines extra-budgetary resources required. Invites commission to adopt the resolution. Any statements? No. Co-sponsors – Iraq, Pakistan, Peru, Bosnia Herzegovia, Honduras, El Salvador, Libya, Lichtenstein, Nigeria, Paraguay, Philippines L5. Rev 1  – no financial implications. Cosponsor – Peru, Norway, …

Read more